Biopharmaceutical company Liquidia Technologies, which counts PPD and Siemens as investors, floated in the middle of its range.
Liquidia Technologies, a US-based biopharmaceutical company backed by industrial equipment and appliance maker Siemens and contract researcher PPD, raised $50m when it floated on the Nasdaq Capital Market last week.
The company issued approximately 5.45 million shares priced at $11.00 each, in the middle of the $10 to $12 range it set earlier this month, giving it a market capitalisation of about $166m.
The company’s shares opened at $12.75 on their first day of trading on Thursday and closed…
